October Pharma S.A.E Share Price

Equities

OCPH

EGS380R1C018

Pharmaceuticals

End-of-day quote Egyptian Exchange 23:00:00 29/04/2024 BST 5-day change 1st Jan Change
100 EGP -.--% Intraday chart for October Pharma S.A.E -.--% -.--%

Financials

Sales 2022 727M 15.19M 1.21B Sales 2023 1.01B 21.12M 1.68B Capitalization 1.2B 25.05M 1.99B
Net income 2022 131M 2.73M 218M Net income 2023 182M 3.8M 302M EV / Sales 2022 2.08 x
Net Debt 2022 316M 6.59M 525M Net Debt 2023 279M 5.82M 463M EV / Sales 2023 1.46 x
P/E ratio 2022
10.6 x
P/E ratio 2023
7.98 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 11.51%
More Fundamentals * Assessed data
Dynamic Chart
1 week
94.02
Extreme 94.02
100.00
1 month
91.03
Extreme 91.03
100.00
Current year
86.41
Extreme 86.41
109.99
1 year
80.00
Extreme 80
110.00
3 years
45.00
Extreme 45
120.00
5 years
29.71
Extreme 29.705
120.00
10 years
15.50
Extreme 15.5
120.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - 30/10/18
Director/Board Member - -
Chief Executive Officer - -
More insiders
Date Price Change Volume
02/05/24 100 -.--% 0
01/05/24 100 -.--% 0
30/04/24 100 -.--% 100
29/04/24 100 -.--% 0
24/04/24 100 -.--% 0

End-of-day quote Egyptian Exchange, April 29, 2024

More quotes
October Pharma S.A.E. specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of cardiovascular, diabetic, gastroenterological, inflammatory, infectious, metabolic, viral, urological, gynecological, dermatological, dental diseases, etc. At the end of 2020, the group had a production site located in Egypt.
More about the company